Atrial fibrillation during adenosine pharmacologic stress testing

Cummings, M Stirling; Raza, Jaffar Ali; Movahed, Assad

doi:10.1016/j.nuclcard.2006.05.006

Cited by 5 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Transient episodes of atrial fibrillation (AF) occur in some patients after the administration of adenosine or ATP for the termination of PSVT; this is probably due to the shortening of action potential duration of atrial myocytes [228,707,708].…”

Section: Atrial Fibrillationmentioning

confidence: 99%

Cardiac purinergic signalling in health and disease

Burnstock

Pelleg

2014

Purinergic Signalling

115

View full text Add to dashboard Cite

This review is a historical account about purinergic signalling in the heart, for readers to see how ideas and understanding have changed as new experimental results were published. Initially, the focus is on the nervous control of the heart by ATP as a cotransmitter in sympathetic, parasympathetic, and sensory nerves, as well as in intracardiac neurons. Control of the heart by centers in the brain and vagal cardiovascular reflexes involving purines are also discussed. The actions of adenine nucleotides and nucleosides on cardiomyocytes, atrioventricular and sinoatrial nodes, cardiac fibroblasts, and coronary blood vessels are described. Cardiac release and degradation of ATP are also described. Finally, the involvement of purinergic signalling and its therapeutic potential in cardiac pathophysiology is reviewed, including acute and chronic heart failure, ischemia, infarction, arrhythmias, cardiomyopathy, syncope, hypertrophy, coronary artery disease, angina, diabetic cardiomyopathy, as well as heart transplantation and coronary bypass grafts.

show abstract

Section: Atrial Fibrillationmentioning

confidence: 99%

Cardiac purinergic signalling in health and disease

Burnstock

Pelleg

2014

Purinergic Signalling

115

View full text Add to dashboard Cite

show abstract

“…Cummings et al [4] recently reported 4 cases of adenosine-induced atrial fibrillation during pharmacological stress testing. Similar to our cohort, their patients had several cardiac risk factors, and had normal or mildly abnormal MPI.…”

Section: Discussionmentioning

confidence: 99%

“…Tachyarrhythmias, such as atrial and ventricular premature beats, and atrial fibrillation may also be observed [2,3]. Atrial fibrillation during pharmacologic stress testing has been recently reported [4], but the incidence and characteristics of this arrhythmia during cardiac stress testing have not been well described.…”

Section: Introductionmentioning

confidence: 99%